Clinical Trials Logo

Platelet Aggregation clinical trials

View clinical trials related to Platelet Aggregation.

Filter by:

NCT ID: NCT01603966 Completed - Clinical trials for Platelet Aggregation

Low Dose Aspirin Studied With the AggreGuide

Start date: April 2012
Phase: N/A
Study type: Observational

This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.

NCT ID: NCT01557335 Completed - Clinical trials for Platelet Aggregation

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

Start date: November 2010
Phase: Phase 1
Study type: Interventional

This study is designed to provide data on platelet aggregation of PA32540 plus clopidogrel dosed separately compared to EC aspirin 81 mg plus EC omeprazole 40 mg plus clopidogrel dosed concomitantly.

NCT ID: NCT01152229 Completed - Bleeding Clinical Trials

Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine

PLACID
Start date: April 2010
Phase: N/A
Study type: Observational

The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize that patients with nuisance or alarming bleeding events on maintenance thienopyridine therapy will have lower levels of platelet reactivity than patients without nuisance or alarming bleeding on thienopyridine therapy.

NCT ID: NCT00923988 Completed - Clinical trials for Endothelial Function

Effect of Passive Smoking on Platelet Function and Endothelial Function

Start date: June 2009
Phase: N/A
Study type: Interventional

Passive smoking is associated with an increased risk for cardiovascular events. However, the exact mechanisms by which passive smoking affects cardiovascular health are not entirely understood. In the present study, the researchers investigate the effects of short-term exposure to secondhand smoke on platelet function and peripheral microvascular endothelial function in healthy individuals. For this purpose, platelet function and endothelial function are measured before and after a 1-hour exposure to secondhand smoke in a concentration that is encountered in bars and restaurants without smoke-free policies. The researchers' hypothesis is that short-term exposure leads to platelet activation and impairment of endothelial function.

NCT ID: NCT00763997 Completed - Clinical trials for Platelet Aggregation

Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages

Start date: February 2004
Phase: N/A
Study type: Interventional

Dipyrone is suggested to inhibit the platelet aggregation comparable to th effect of traditional analgetic substances like Ibuprofen. To verify this hypothesis the investigators conducted the study in comparing patients undergoing traumatologic, visceral or plastic surgical procedures. The investigators randomized them to four groups receiving common analgetic doses of either dipyrone, acetaminophen (paracetamol) or valdecoxib/parecoxib. The investigators took blood samples before initiation of the study drug, 1h, 4hs and 24hs after first intake. The investigators compared the aggregation via aggregometry of platelet rich plasma.

NCT ID: NCT00233428 Completed - Clinical trials for Platelet Aggregation

Study to Determine Racial and Gender Differences in Platelet Aggregation

Start date: May 2005
Phase: Phase 1
Study type: Observational

The purpose of this study is to see if there is a racial and/or gender difference in platelet aggregation.